- Home
- ANEB vs BLIV Comparison
ANEB vs BLIV Comparison
Compare ANEB & BLIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- BLIV
- Stock Information
- Founded
- ANEB 2020
- BLIV 2014
- Country
- ANEB United States
- BLIV Singapore
- Employees
- ANEB N/A
- BLIV N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- BLIV
- Sector
- ANEB Health Care
- BLIV
- Exchange
- ANEB Nasdaq
- BLIV NYSE
- Market Cap
- ANEB 39.0M
- BLIV 39.8M
- IPO Year
- ANEB 2021
- BLIV 2025
- Fundamental
- Price
- ANEB $1.07
- BLIV $4.24
- Analyst Decision
- ANEB Buy
- BLIV
- Analyst Count
- ANEB 1
- BLIV 0
- Target Price
- ANEB $8.00
- BLIV N/A
- AVG Volume (30 Days)
- ANEB 14.8K
- BLIV 223.3K
- Earning Date
- ANEB 05-19-2025
- BLIV 01-01-0001
- Dividend Yield
- ANEB N/A
- BLIV N/A
- EPS Growth
- ANEB N/A
- BLIV N/A
- EPS
- ANEB N/A
- BLIV N/A
- Revenue
- ANEB N/A
- BLIV $1,915,838.00
- Revenue This Year
- ANEB N/A
- BLIV N/A
- Revenue Next Year
- ANEB N/A
- BLIV N/A
- P/E Ratio
- ANEB N/A
- BLIV N/A
- Revenue Growth
- ANEB N/A
- BLIV N/A
- 52 Week Low
- ANEB $0.80
- BLIV $2.69
- 52 Week High
- ANEB $3.18
- BLIV $6.40
- Technical
- Relative Strength Index (RSI)
- ANEB 43.98
- BLIV N/A
- Support Level
- ANEB $1.02
- BLIV N/A
- Resistance Level
- ANEB $1.30
- BLIV N/A
- Average True Range (ATR)
- ANEB 0.10
- BLIV 0.00
- MACD
- ANEB 0.01
- BLIV 0.00
- Stochastic Oscillator
- ANEB 34.29
- BLIV 0.00
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.